"Adaptogens" and "brainergy" stacks — ashwagandha, rhodiola, lion's mane, L-theanine — are among the fastest-growing categories in wellness. The marketing promises calm, focus, and resilience in a capsule. Some of these ingredients do have real, if modest, clinical support. One of them also carries a liver-safety warning that rarely makes it into the TikTok pitch. Here's the clinical picture.
Ashwagandha is the strongest of the group — but not harmless. Meta-analyses show it significantly reduces serum cortisol and anxiety versus placebo, yet it is a documented cause of liver injury and should not be treated as "just an herb."
Rhodiola, reishi, and maca are weaker than the marketing. The evidence is contradictory, thin, or mis-applied — none is a reliable stress or cortisol agent.
Caffeine + L-theanine is the best-studied "brainergy" combo. It modestly improves attention and focus; most other nootropics (lion's mane, omega-3 supplements) are early-stage rather than proven.
"Balancing hormones" is a marketing phrase, not a measurable effect. No adaptogen replaces evaluation and treatment of an actual hormone condition.
Adaptogens are a marketing category of herbs said to help the body "adapt" to stress and normalize cortisol. It's a loose, non-clinical term. That doesn't make the individual herbs worthless — but it does mean each one has to be judged on its own trial data rather than on the category label.
Mixed Mixed-to-solid for anxiety and cortisol — but see the safety warning. Meta-analyses of randomized trials show ashwagandha significantly reduces serum cortisol and anxiety scores versus placebo. Effects on perceived stress are less consistent, and trials are small, short, and often industry-funded.
Typical trial doses are roughly 250–600 mg/day of a standardized root extract over 6–8 weeks. The signal for anxiety is genuine. But ashwagandha is not the harmless "just an herb" it's often portrayed as.
Safety warning — liver injury. The U.S. National Institutes of Health LiverTox database classifies ashwagandha as a likely cause of clinically apparent liver injury. Injury typically appears 2–12 weeks after starting, often with jaundice, dark urine, and itching. Most cases resolve after stopping, but acute liver failure requiring transplant — and deaths — have occurred, particularly in people with pre-existing liver disease. Anyone with liver disease should avoid it, and anyone taking it who develops those symptoms should stop and seek testing.
Weak Weak-to-mixed across the board.
Rhodiola rosea is promoted for fatigue, but a systematic review found contradictory results and methodological flaws; the NIH's complementary-health center concludes there isn't enough reliable evidence for any use. Reishi mushroom has essentially no credible trial evidence for the stress and cortisol claims it's sold under. Maca is marketed for energy and "hormone balance," but the data are preliminary — and it isn't a stress or cortisol agent at all, so it's often mis-sold.
"Brainergy" — brain plus energy — is the 2026 umbrella term for focus-and-mood stacks. Here's how the headline ingredients hold up.
| Ingredient | Best-supported use | Verdict |
|---|---|---|
| Caffeine + L-theanine | Acute attention and focus, including when sleep-deprived | Mixed–Solid (the best-studied of the group; modest effect) |
| L-theanine alone | Calm focus | Mixed (promising, not conclusive) |
| Lion's mane | Memory, mood over weeks | Weak–Mixed (mechanistically interesting, human data thin) |
| Omega-3 (fish) | Long-term cognitive protection from diet | Mixed–Solid for dietary intake; Weak as a supplement to reverse decline |
This is the standout. The combination has reasonably consistent randomized-trial support for attention and task-switching, including a 2025 crossover trial in sleep-deprived adults, and it's the best-studied of these focus ingredients. The effect is real but modest — sharper focus, not a new brain. Note that the benefits and the risks (anxiety, palpitations, disrupted sleep) both come mostly from the caffeine half.
Lion's mane promotes nerve growth factor in lab models, and a few small trials hint at memory, sleep, and mood benefits over several weeks. Acute single-dose studies mostly show little. It's a reasonable low-risk experiment, but it is not the proven "brain booster" it's marketed as.
Higher dietary omega-3 intake (fatty fish) is associated with lower rates of cognitive decline in large population studies. But supplement trials, especially in people who already have Alzheimer's disease, are inconsistent. Diet first; supplements are unproven for reversing decline.
How we approach this at Naya. We're comfortable discussing a caffeine + L-theanine focus routine or dietary omega-3 strategy, because the risk-benefit is favorable. For ashwagandha, we'd screen your liver history and current medications first — the kind of check a supplement retailer never does. And we're honest that lion's mane and omega-3 supplements are early-stage rather than proven.
Curious how cortisol claims connect to all this? See our companion piece on "cortisol face" and "adrenal fatigue". For the wider framework on evaluating supplement trends, see our functional medicine evidence guide.
For many healthy adults it's well tolerated short-term, but it carries a documented risk of liver injury and should be avoided by anyone with liver disease or who is pregnant. Because supplements aren't tightly regulated for purity, and because ashwagandha can interact with thyroid and sedative medications, it's worth reviewing with a clinician rather than self-prescribing indefinitely.
The combination with the most consistent evidence is caffeine plus L-theanine, which improves attention with a calmer edge than caffeine alone. The effect is modest, and the caffeine component drives both the benefit and the side effects.
The evidence is early and mixed. Lab studies are intriguing and a few small human trials suggest modest benefits over weeks, but there's no strong proof it meaningfully boosts memory in healthy people. It's low-risk to try, but keep expectations realistic.
"Balancing hormones" is a marketing phrase, not a measurable effect. Ashwagandha has modest evidence for lowering cortisol and anxiety; the others have little support for hormonal claims. None replace evaluation and treatment of an actual hormone condition.
Two California locations and statewide telehealth — click a card to book, or call to schedule a consult.
21800 Devonshire St. Suite B
Chatsworth, CA 91311
601 East Arrellaga Street, Suite 101
Santa Barbara, CA 93103
Educational content, not medical advice. Speak with a qualified clinician before starting or stopping any supplement, medication, or treatment. Naya Wellness · Chatsworth & Santa Barbara, California.